Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

12

Revenue 2017

Bayer

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bayer's 2013 sales performance.

Bayer

Bayer’s Vitrakvi scores first EU tumour-agnostic drug approval

Bayer’s Vitrakvi scores first EU tumour-agnostic drug approval The EU approval is good news for Bayer, as it faces increasing  competition from Roche’s rival tumour-agnostic drug Rozlytrek (entrectinib). ... Now that Vitrakvi has received EU approval, Bayer is sure to start negotiating with NICE, which had

J&J puts pressure on rivals with new Erleada okay in prostate cancer

J&J puts pressure on rivals with new Erleada okay in prostate cancer Since then, Bayer and Orion’s  Nubeqa(darolutamide) has also joined the fray in nmCRPC after an FDA approval in July, adding to the competitive pressure in that indication.

Pharma industry consensus: fix data strategy before pushing artificial intelligence and machine learning applications

Pharma industry consensus: fix data strategy before pushing artificial intelligence and machine learning applications insights. According to Uwe Dalichow, Head of Global Marketing Operations, Bayer: “Data analytics is the springboard for meaningful applications of next-gen AI and ML technology.

New hires at Bayer, Eisai and Accord Healthcare

New hires at Bayer, Eisai and Accord Healthcare The latest movers in pharma. Bayer appoints new head of pharma business development &licensing. ... Bayer has bolstered its pharma division, appointing Marianne De Backer (pictured below) as its new head of business development &licensing.

Lilly’s Levi Garraway will replace Sandra Horning as Roche CMO

Lilly’s Levi Garraway will replace Sandra Horning as Roche CMO The company has just picked up a new approval for targeted cancer drug Rozlytrek(entrectinib), a rival to Bayer’s Vitrakvi (larotrectinib), and for anti-CD79b antibody drug conjugate Polivy (polatuzumab

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa
Ben Speller shares his thoughts on the value of disease specific congresses...
OPEN Health use PR to support clinical trial recruitment
International Clinical Trials Day finds clinical research in the spotlight like never before, with any news coming from the many studies into potential vaccines and treatments for SARS-CoV-2...
Covid-19: what could it mean for the diabetic population?
Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it...

Infographics